Drugs Made In America Acquisition Corp.
DMAAR- Exchange
- Nasdaq
- Industry
- Blank Checks
- SEC CIK
- 0002028614
No open-market purchases or sales by Drugs Made In America Acquisition Corp. insiders were filed in the last 90 days; 28 institutions reported holding it in 13F filings for Q2 2026, worth $1.27M in total; no superinvestor holds it.
13F holders, Q2 2025
Institutional positions in Drugs Made In America Acquisition Corp. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 24
- +6 vs. Q1 2025
- Shares held
- 18.3M
- +4.34M (+31.1%) vs. Q1 2025
- Total value
- $2.22M
- +$515.2K (+30.3%) vs. Q1 2025
- New holders
- 7
- 2 more added
- Sold out
- 1
- 2 more reduced
1 institution that held it in Q1 2025 haven't filed for Q2 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting DMAAR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 28 | $1.27M |
| Q1 2026 | 35 | $872.3K |
| Q4 2025 | 32 | $3.02M |
| Q3 2025 | 32 | $3.71M |
| Q2 2025 | 24 | $2.22M |
| Q1 2025 | 19 | $1.72M |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Drugs Made In America Acquisition Corp.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bulldog Investors, LLP | 72,964 | $8.77K | 0.00% | +72,964 | New |
| Verition Fund Management LLC | 100,000 | $12.5K | 0.00% | +100,000 | New |
| Quarry LP | 150,000 | $18.0K | 0.00% | 00.0% | Unchanged |
| Mizuho Securities USA LLC | 209,897 | $21.0K | 0.00% | +209,897 | New |
| Whitebox Advisors LLC | 400,000 | $48.1K | 0.00% | 00.0% | Unchanged |
| Schonfeld Strategic Advisors LLC | 414,492 | $49.8K | 0.00% | +214,492+107.2% | Added |
| Cantor Fitzgerald, L. P. | 500,000 | $60.1K | 0.00% | 00.0% | Unchanged |
| LMR Partners LLP | 500,000 | $60.1K | 0.00% | 00.0% | Unchanged |
| CNH Partners LLC | 500,000 | $62.5K | 0.00% | 00.0% | Unchanged |
| Westchester Capital Management, LLC | 500,000 | $62.5K | 0.00% | +500,000 | New |
| Atw Spac Management LLC | 570,000 | $68.5K | 0.10% | 00.0% | Unchanged |
| Boothbay Fund Management, LLC | 570,000 | $68.5K | 0.00% | +570,000 | New |
| Wolverine Asset Management LLC | 601,038 | $72.2K | 0.00% | −2,000−0.3% | Reduced |
| Heights Capital Management, Inc | 633,816 | $79.2K | 0.02% | +633,816 | New |
| Clear Street LLC | 672,087 | $80.8K | 0.00% | +121,911+22.2% | Added |
| Mangrove Partners | 850,000 | $102.2K | 0.01% | 00.0% | Unchanged |
| Highbridge Capital Management LLC | 850,000 | $106.2K | 0.01% | 00.0% | Unchanged |
| Crossingbridge Advisors, LLC | 850,000 | $106.2K | 0.09% | 00.0% | Unchanged |
| Aristeia Capital LLC | 887,834 | $106.7K | 0.00% | −12,166−1.4% | Reduced |
| Glazer Capital, LLC | 1,300,000 | $156.0K | 0.01% | 00.0% | Unchanged |
| Harraden Circle Investments, LLC | 1,500,000 | $180.3K | 0.05% | 00.0% | Unchanged |
| Hudson Bay Capital Management LP | 1,800,000 | $224.8K | 0.00% | 00.0% | Unchanged |
| Polar Asset Management Partners Inc. | 1,900,000 | $228.4K | 0.01% | 00.0% | Unchanged |
| Toronto Dominion Bank | 1,945,600 | $233.9K | 0.00% | +1,945,600 | New |
| Warberg Asset Management LLC | 0 | $0 | 0.00% | −18,443−100.0% | Sold out |
| Mizuho Securities USA LLC | – | – | – | – | Not filed |